UOC
OXFD

UBS O'Connor’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

UBS O'Connor’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50,705
Closed -$456K – 523
2016
Q2 		$456K Sell
50,705
-5,595
-10% -$54.8K 0.01% 346
2016
Q1 		$558K Hold
56,300
– – 0.01% 357
2015
Q4 		$647K Sell
56,300
-23,164
-29% -$287K 0.01% 349
2015
Q3 		$1.07M Sell
79,464
-6,355
-7% -$86.1K 0.02% 338
2015
Q2 		$1.19M Buy
85,819
+10,910
+15% +$148K 0.02% 377
2015
Q1 		$1.05M Buy
+74,909
New +$1.02M 0.02% 400

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS O'Connor's OXFD Position: Q3 2016 in Review

UBS O'Connor sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2016, closing a stake of 50,705 shares — an estimated $456K sold.

UBS O'Connor first reported a position in OXFD in Q1 2015 and held it in 6 quarters. The position peaked at $1.19M in Q2 2015. 62 funds tracked by Wall St. Rank hold OXFD as of Q3 2016.

  • UBS O'Connor reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2016 after selling out during the quarter.
  • UBS O'Connor sold 50,705 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2016, an estimated $456K.
  • UBS O'Connor first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2015 and held it in 6 quarters.
  • UBS O'Connor's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.19M in Q2 2015.
  • 62 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2016.

Based on UBS O'Connor's 13F filing for Q3 2016, filed 14 Nov 2016.